{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:59:58Z","timestamp":1762505998258},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,11,4]],"date-time":"2012-11-04T00:00:00Z","timestamp":1351987200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00262-012-1364-8","type":"journal-article","created":{"date-parts":[[2012,11,3]],"date-time":"2012-11-03T04:42:17Z","timestamp":1351917737000},"page":"597-603","source":"Crossref","is-referenced-by-count":16,"title":["Palmitate-derivatized human IL-2: a potential anticancer immunotherapeutic of low systemic toxicity"],"prefix":"10.1007","volume":"62","author":[{"given":"Sharon H.","family":"Chou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya V.","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajun","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lipeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gnanasekar","family":"Munirathinam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Pipathsouk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaiah","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aoshuang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoxing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,4]]},"reference":[{"key":"1364_CR1","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.4049\/jimmunol.131.4.1808","volume":"131","author":"KA Smith","year":"1983","unstructured":"Smith KA, Favata MF, Oroszlan S (1983) Production and characterization of monoclonal antibodies to human interleukin 2: strategy and tactics. J Immunol. 131:1808\u20131815","journal-title":"J Immunol."},{"key":"1364_CR2","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/0161-5890(81)90024-9","volume":"18","author":"RJ Robb","year":"1981","unstructured":"Robb RJ, Smith KA (1981) Heterogeneity of human T-cell growth factor(s) due to variable glycosylation. Mol Immunol 18:1087\u20131094","journal-title":"Mol Immunol"},{"key":"1364_CR3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nri1901","volume":"6","author":"TA Waldmann","year":"2006","unstructured":"Waldmann TA (2006) The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol 6:595\u2013601","journal-title":"Nat Rev Immunol"},{"key":"1364_CR4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/CJI.0b013e318177a4ba","volume":"31","author":"N Acquavella","year":"2008","unstructured":"Acquavella N, Kluger H, Rhee J, Farber L, Tara H, Ariyan S et al (2008) Toxicity and activity of a twice daily high-dose bolus interleukin 2 regimen in patients with metastatic melanoma and metastatic renal cell cancer. J Immunother 31:569\u2013576","journal-title":"J Immunother"},{"key":"1364_CR5","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/jps.21596","volume":"98","author":"MA Shaker","year":"2009","unstructured":"Shaker MA, Younes HM (2009) Interleukin-2: evaluation of routes of administration and current delivery systems in cancer therapy. J Pharm Sci 98:2268\u20132298","journal-title":"J Pharm Sci"},{"key":"1364_CR6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0092-8674(94)90169-4","volume":"76","author":"KA Hogquist","year":"1994","unstructured":"Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR (1994) T cell receptor antagonist peptides induce positive selection. Cell 76:17\u201327","journal-title":"Cell"},{"key":"1364_CR7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0022-1759(93)90258-9","volume":"158","author":"SA Kim","year":"1993","unstructured":"Kim SA, Peacock JS (1993) The use of palmitate-conjugated protein A for coating cells with artificial receptors which facilitate intercellular interactions. J Immunol Methods 158:57\u201365","journal-title":"J Immunol Methods"},{"key":"1364_CR8","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1158\/0008-5472.CAN-06-0435","volume":"66","author":"G Zheng","year":"2006","unstructured":"Zheng G, Liu S, Wang P, Xu Y, Chen A (2006) Arming tumor-reactive T cells with costimulator B7\u20131 enhances therapeutic efficacy of the T cells. Cancer Res 66:6793\u20136799","journal-title":"Cancer Res"},{"key":"1364_CR9","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/00002371-200211000-00004","volume":"25","author":"A Mustafa","year":"2002","unstructured":"Mustafa A, McKallip RJ, Fisher M, Duncan R, Nagarkatti PS, Nagarkatti M (2002) Regulation of interleukin-2-induced vascular leak syndrome by targeting CD44 using hyaluronic acid and anti-CD44 antibodies. J Immunother 25:476\u2013488","journal-title":"J Immunother"},{"key":"1364_CR10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0022-1759(89)90351-7","volume":"124","author":"AS Colsky","year":"1989","unstructured":"Colsky AS, Peacock JS (1989) Palmitate-derivatized antibodies can function as surrogate receptors for mediating specific cell\u2013cell interactions. J Immunol Methods 124:179\u2013187","journal-title":"J Immunol Methods"},{"key":"1364_CR11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1385\/IR:27:2-3:565","volume":"27","author":"ML Tykocinski","year":"2003","unstructured":"Tykocinski ML, Chen A, Huang JH, Weber MC, Zheng G (2003) New designs for cancer vaccine and artificial veto cells: an emerging palette of protein paints. Immunol Res 27:565\u2013574","journal-title":"Immunol Res"},{"key":"1364_CR12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4049\/jimmunol.164.2.705","volume":"164","author":"A Chen","year":"2000","unstructured":"Chen A, Zheng G, Tykocinski ML (2000) Hierarchical costimulator thresholds for distinct immune responses: application of a novel two-step Fc fusion protein transfer method. J Immunol 164:705\u2013711","journal-title":"J Immunol"},{"key":"1364_CR13","first-page":"8127","volume":"61","author":"G Zheng","year":"2001","unstructured":"Zheng G, Chen A, Sterner RE, Zhang PJ, Pan T, Kiyatkin N et al (2001) Induction of antitumor immunity via intratumoral tetra-costimulator protein transfer. Cancer Res 61:8127\u20138134","journal-title":"Cancer Res"},{"key":"1364_CR14","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.4049\/jimmunol.178.5.3301","volume":"178","author":"S Liu","year":"2007","unstructured":"Liu S, Breiter DR, Zheng G, Chen A (2007) Enhanced antitumor responses elicited by combinatorial protein transfer of chemotactic and costimulatory molecules. J Immunol 178:3301\u20133306","journal-title":"J Immunol"},{"key":"1364_CR15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1158\/1078-0432.CCR-06-1913","volume":"13","author":"S Liu","year":"2007","unstructured":"Liu S, Foster BA, Chen T, Zheng G, Chen A (2007) Modifying dendritic cells via protein transfer for antitumor therapeutics. Clin Cancer Res 13:283\u2013291","journal-title":"Clin Cancer Res"},{"key":"1364_CR16","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1158\/0008-5472.CAN-06-2622","volume":"67","author":"A Chen","year":"2007","unstructured":"Chen A, Liu S, Park D, Kang Y, Zheng G (2007) Depleting intratumoral CD4+ CD25+ regulatory T cells via FasL protein transfer enhances the therapeutic efficacy of adoptive T Cell transfer. Cancer Res 67:1291\u20131298","journal-title":"Cancer Res"},{"key":"1364_CR17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cellimm.2004.11.005","volume":"231","author":"A Chen","year":"2004","unstructured":"Chen A, Xu H, Choi Y, Wang B, Zheng G (2004) TRANCE counteracts FasL-mediated apoptosis of murine bone marrow-derived dendritic cells. Cell Immunol 231:40\u201348","journal-title":"Cell Immunol"},{"key":"1364_CR18","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0008-8749(03)00069-8","volume":"221","author":"A Chen","year":"2003","unstructured":"Chen A, Zheng G, Tykocinski ML (2003) Quantitative interplay between activating and pro-apoptotic signals dictates T cell responses. Cell Immunol 221:128\u2013137","journal-title":"Cell Immunol"},{"key":"1364_CR19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1089\/vim.2009.0048","volume":"22","author":"Y Kang","year":"2009","unstructured":"Kang Y, Chen A, Wang B, Zheng G (2009) Protein transfer enhances cellular immune responses to DNA vaccination against SARS-CoV. Viral Immunol 22:417\u2013422","journal-title":"Viral Immunol"},{"key":"1364_CR20","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.iy.04.040186.003341","volume":"4","author":"SA Rosenberg","year":"1986","unstructured":"Rosenberg SA, Lotze MT (1986) Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes. Annu Rev Immunol 4:681\u2013709","journal-title":"Annu Rev Immunol"},{"key":"1364_CR21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4049\/jimmunol.86.2.228","volume":"86","author":"HJ Winn","year":"1961","unstructured":"Winn HJ (1961) Immune mechanisms in homotransplantation. II. Quantitative assay of the immunologic activity of lymphoid cells stimulated by tumor homografts. J Immunol 86:228\u2013239","journal-title":"J Immunol"},{"key":"1364_CR22","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1182\/blood-2005-06-2399","volume":"107","author":"M Ahmadzadeh","year":"2006","unstructured":"Ahmadzadeh M, Rosenberg SA (2006) IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients. Blood 107:2409\u20132414","journal-title":"Blood"},{"key":"1364_CR23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1211\/0022357021778268","volume":"54","author":"EP Goldberg","year":"2002","unstructured":"Goldberg EP, Hadba AR, Almond BA, Marotta JS (2002) Intratumoral cancer chemotherapy and immunotherapy: opportunities for nonsystemic preoperative drug delivery. J Pharm Pharmacol 54:159\u2013180","journal-title":"J Pharm Pharmacol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-012-1364-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-012-1364-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-012-1364-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T14:26:48Z","timestamp":1687789608000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-012-1364-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,4]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["1364"],"URL":"https:\/\/doi.org\/10.1007\/s00262-012-1364-8","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,4]]}}}